[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 5030 followers
Created: 2025-07-20 14:25:28 UTC

🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists

Head-to-head trials directly comparing tirzepatide vs. semaglutide or exenatide remain absent. Agent selection remains data-limited. #GLP1 #trialgap $LLY $VKTX


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946939520340906411/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[longterm](/topic/longterm)
[weight loss](/topic/weight-loss)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)
[$vktx](/topic/$vktx)

[Post Link](https://x.com/AponiaAnalytics/status/1946939520340906411)